PS
COLL icon

Principal Securities’s Collegium Pharmaceutical COLL Stock Holding History

Principal Securities’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-900
Closed -$31.5K – 1757
2025
Q3 		$31.5K Hold
900
– – ﹤0.01% 2194
2025
Q2 		$26.6K Buy
900
+5
+0.6% +$143 ﹤0.01% 2188
2025
Q1 		$25.6K Hold
895
– – ﹤0.01% 2082
2024
Q4 		$25.6K Hold
895
– – ﹤0.01% 2076
2024
Q3 		$34.6K Sell
895
-230
-20% -$8.2K ﹤0.01% 1854
2024
Q2 		$36.2K Hold
1,125
– – ﹤0.01% 1767
2024
Q1 		$43.7K Sell
1,125
-178
-14% -$6.23K ﹤0.01% 1633
2023
Q4 		$40.1K Buy
+1,303
New +$32.6K ﹤0.01% 1587

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Principal Securities's COLL Position: Q4 2025 in Review

Principal Securities sold out of Collegium Pharmaceutical (COLL) in Q4 2025, closing a stake of 900 shares — an estimated $31.5K sold.

Principal Securities first reported a position in COLL in Q4 2023 and held it in 8 quarters. The position peaked at $43.7K in Q1 2024. 278 funds tracked by Wall St. Rank hold COLL as of Q4 2025.

  • Principal Securities reported no remaining Collegium Pharmaceutical position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 900 Collegium Pharmaceutical shares in Q4 2025, an estimated $31.5K.
  • Principal Securities first reported a position in Collegium Pharmaceutical in Q4 2023 and held it in 8 quarters.
  • Principal Securities's Collegium Pharmaceutical position peaked at $43.7K in Q1 2024.
  • 278 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.